Mylan
FDA Approves METHOTREXATE — Mylan Pharmaceuticals Inc.
# FDA Approval Newswire Mylan Pharmaceuticals Inc. received FDA approval for its oral methotrexate sodium formulation (ANDA081235), expanding the com...
Financial News Archive
SEC EDGAR · Federal Reserve · FDA · BLS · Updated every 60s
Actavis
FDA Approves MINOCYCLINE HYDROCHLORIDE — Actavis Pharma, Inc.
Actavis Pharma, Inc. has received approval for its generic version of minocycline hydrochloride (ANDA063181), a timely move that increases competition...
AIPING
FDA Approves Unknown Drug — AIPING PHARM INC
Aiping Pharm Inc secured FDA approval via this Abbreviated New Drug Application, a regulatory milestone that establishes the pathway for market distri...
KING
FDA Approves Unknown Drug — KING PHARMS LLC
KING PHARMS LLC has received FDA regulatory approval for NDA019901, establishing formal clearance for a new pharmaceutical entry. This development car...
Teva
FDA Approves METHOTREXATE — Teva Pharmaceuticals USA, Inc.
# FDA Approves Teva Pharmaceuticals' Generic Methotrexate Oral Formulation Teva Pharmaceuticals USA, Inc. received FDA approval for its generic metho...
ALVOGEN
FDA Approves Unknown Drug — ALVOGEN
ALVOGEN has received FDA approval for its Abbreviated New Drug Application (ANDA063067), reinforcing the company's competitive positioning in the gene...
Hospira,
FDA Approves CYTARABINE — Hospira, Inc.
Hospira, Inc. received approval on June 4, 1990, for its intrathecal formulation of CYTARABINE (ANDA071868), a critical therapeutic addressing the sig...
TerSera
FDA Approves ZOLADEX — TerSera Therapeutics LLC
# FDA Drug Approval: TerSera Therapeutics' ZOLADEX TerSera Therapeutics LLC received FDA approval for ZOLADEX (goserelin acetate), a subcutaneous gon...
AbbVie
FDA Approves DEPAKOTE SPRINKLES — AbbVie Inc.
# FDA Approval Alert AbbVie Inc.'s DEPAKOTE SPRINKLES (divalproex sodium) oral formulation received FDA approval on September 12, 1989, establishing ...
PFIZER
FDA Approves Unknown Drug — PFIZER
# FDA Approves Pfizer Drug (NDA050639) Pfizer received FDA approval for a new drug application on August 30, 1989, expanding the company's pharmaceut...
ORGANON
FDA Approves Unknown Drug — ORGANON
Organon announced today that the FDA has cleared the marketing of NDA019796, a decision that allows the company to expand its product portfolio and ca...
Strides
FDA Approves ACETAMINOPHEN AND CODEINE PHOSPHATE — Strides Pharma Science Limited
Strides Pharma Science Limited announced the FDA approval of its ANDA089805 for oral Acetaminophen and Codeine Phosphate, positioning the company to c...
Strides
FDA Approves ACETAMINOPHEN AND CODEINE PHOSPHATE — Strides Pharma Science Limited
Strides Pharma Science Limited announced the FDA approval for Acetaminophen and Codeine Phosphate, a move anticipated to intensify competition in the ...
ALMAJECT
FDA Approves Unknown Drug — ALMAJECT
The FDA approved Unknown Drug from ALMAJECT under application ANDA062943 on 1988-09-29....
Hospira,
FDA Approves LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE — Hospira, Inc.
# FDA Approves Hospira's Lidocaine Hydrochloride and Epinephrine Combination Injection Hospira, Inc. received FDA approval for its lidocaine hydrochl...
Hospira,
FDA Approves LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE — Hospira, Inc.
# FDA Approves Hospira's Lidocaine Hydrochloride and Epinephrine for Epidural Use Hospira, Inc. has received FDA approval for its lidocaine hydrochlo...
Hospira,
FDA Approves LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE — Hospira, Inc.
Hospira, Inc. confirmed the FDA's approval of its ANDA for LidoCaine Hydrochloride and Epinephrine intended for epidural administration, a product lau...
Harrow
FDA Approves IOPIDINE 1% — Harrow Eye, LLC
# FDA Approves Harrow Eye's IOPIDINE (Apraclonidine Hydrochloride) for Ophthalmic Use Harrow Eye, LLC has received FDA approval for IOPIDINE 1% (apra...
Viatris
FDA Approves EPIPEN — Viatris Specialty LLC
Viatris Specialty LLC secured FDA approval for its epinephrine injectable product, expanding the availability of generic alternatives to the branded E...
ALMAJECT
FDA Approves Unknown Drug — ALMAJECT
FDA approval for ALMAJECT’s ANDA signals the regulatory clearance to manufacture this generic substance, positioning the company to enter the market a...